AI in Genomics Market to Reach USD 21.08 Billion by 2034, Growing at 39.74% CAGR

According to a report by Polaris Market Research, the global AI in Genomics Market was valued at USD 1.04 billion in 2025 and is projected to reach USD 21.08 billion by 2034. The market is expected to expand at a CAGR of 39.74% from 2026 to 2034. Growth is supported by rising adoption of artificial intelligence in genomic analysis, increasing demand for precision medicine, and growing investments in genomic research programs worldwide.

What Is Driving AI in Genomics Market Growth?

AI in genomics applies artificial intelligence technologies to the analysis, interpretation, and management of genomic data. These technologies help researchers and healthcare providers identify genetic variations, assess disease risks, accelerate drug discovery, and improve precision medicine outcomes. Market expansion is supported by increasing genomic sequencing activity, healthcare digitization, precision medicine programs, and investment in biotechnology research.

The rapid expansion of genomic data is increasing the need for scalable analytics platforms that can process complex datasets efficiently. Improvements in machine learning algorithms and cloud-based genomic platforms are helping research organizations and healthcare institutions analyze genetic patterns, discover biomarkers, and support more personalized clinical decision-making.

Key Trends Shaping the AI in Genomics Industry

Precision Medicine Expansion

Precision medicine is increasing demand for advanced genomic analysis tools used in disease risk assessment, personalized treatment strategies, and clinical decision support. Wider acceptance of genetic testing and biomarker-based therapies is generating larger volumes of genomic data that require sophisticated AI-enabled analytics.

Genomic Data Expansion and AI Technology Advancement

Growing sequencing activity is creating substantial genomic datasets across research laboratories and healthcare organizations. AI technologies can accelerate analysis, improve interpretation accuracy, and help identify genetic patterns and disease biomarkers, while advances in algorithms continue to expand the range of genomic applications.

Multi-Omics and AI-Driven Drug Discovery

The integration of genomics with proteomics and transcriptomics is supporting broader multi-omics research. AI is also being applied to genetic target discovery and treatment-outcome prediction, creating opportunities in regenerative medicine, organoid research, and AI-assisted drug discovery.

👉 Explore The Complete Comprehensive Report Here: https://www.polarismarketresearch.com/industry-analysis/ai-in-genomics-market

Market Segmentation: Breaking Down the AI in Genomics Market

Polaris Market Research segments the AI in Genomics Market by offering, application, end user, and region, providing a detailed view of the technology platforms and use cases shaping market demand.

By Offering

The offering segmentation includes software, services, and cloud platforms. Software dominated the market with a 50.0% share in 2025, supported by adoption of AI-powered genomic analysis platforms across research institutes and healthcare organizations. Services are projected to grow at the fastest CAGR of 40.2% during the forecast period as demand rises for consulting, implementation, data management, and genomic analysis support.

By Application

Applications include variant interpretation, population genomics, drug target discovery, clinical diagnostics, and precision medicine. Variant interpretation held the largest application share at 26.0% in 2025, supported by growing genomic sequencing for disease diagnosis and precision medicine. Population genomics is projected to grow at the fastest CAGR of 40.8% during the forecast period, driven by government-funded genomic research and national sequencing initiatives.

By End User

End users include research institutes, hospitals, biopharmaceutical companies, and diagnostic laboratories. Research institutes dominated with a 34.0% share in 2025 due to extensive use of genomic analysis technologies in academic and clinical research. Hospitals are projected to grow at the fastest CAGR of 40.3%, supported by precision medicine adoption and integration of genomic testing into clinical workflows.

Regional Outlook: North America Led the AI in Genomics Market in 2025

North America dominated the global market with a 43.0% share in 2025, supported by advanced healthcare facilities, adoption of genomic technologies, research funding, and precision medicine programs. Asia Pacific is expected to record the fastest regional growth at a CAGR of 41.5% during the forecast period as China, Japan, India, South Korea, Hong Kong, and Australia increase investments in genomic research and healthcare innovation. Europe also held a considerable 26.0% share in 2025, supported by genomic research activity and healthcare policies.

👉 Explore the Full AI in Genomics Market Report: https://www.polarismarketresearch.com/industry-analysis/ai-in-genomics-market

Competitive Landscape: Leading AI in Genomics Companies

Key players profiled in the report include DNAnexus, Inc., Fabric Genomics, Inc., Google DeepMind, IBM Corporation, Illumina, Inc., Microsoft Corporation, NVIDIA Corporation, Oracle Corporation, SAP SE, SOPHiA GENETICS SA, Tempus AI, Inc., and Thermo Fisher Scientific Inc. Competition spans genomic technology, AI platforms, cloud computing, healthcare analytics, and specialized genomics software.

Market participants are advancing AI models, genomic data analysis capabilities, cloud infrastructure, workflow automation, multi-omics integration, and compliance-ready data management. Partnerships and technology development are helping companies expand precision medicine, clinical genomics, and research applications.

Why It Matters for Buyers Evaluating the AI in Genomics Market

For healthcare organizations, biotechnology companies, research institutes, investors, procurement teams, and strategy professionals, the report provides market size, growth forecasts, segment analysis, regional outlook, and competitive intelligence. The outlook highlights how precision medicine, genomic data growth, AI technology advancement, research funding, and strategic partnerships are shaping the market through 2034.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Mycelium Market

Europe Pneumococcal Vaccine Market

In-Vehicle Infotainment Market

Cell & Gene Therapy Bioanalytical Testing Services Market

Europe Pneumococcal Vaccine Market

E-Pharmacy Market

V2X Cybersecurity Market

Increasing Prevalence and New Product Launches to Propel Growth

Cloud Computing Market